Page last updated: 2024-08-21

sapropterin and Dyslipidemia

sapropterin has been researched along with Dyslipidemia in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carrizzo, A; Civitillo, F; Damato, A; Franco, E; Marino, M; Pompeo, F; Puca, A; Santini, L; Traficante, A; Trimarco, V; Vecchione, C	1
Ding, H; Triggle, CR	1
Corti, R; Flammer, A; Hermann, F; Lüscher, TF; Noll, G; Spieker, LE; Sudano, I	1

Reviews

2 review(s) available for sapropterin and Dyslipidemia

Article	Year
Endothelial dysfunction in diabetes: multiple targets for treatment. Pflugers Archiv : European journal of physiology, 2010, Volume: 459, Issue:6 Topics: Animals; Biological Factors; Biopterins; Blood Glucose; Calcium; Cell Communication; Connexins; Diabetes Mellitus; Diabetic Angiopathies; Dyslipidemias; Endothelium-Dependent Relaxing Factors; Endothelium, Vascular; Humans; Hypercalcemia; Hyperglycemia; Hypertension; Nitric Oxide Synthase Type III; Oxidative Stress; Transient Receptor Potential Channels	2010
Protection of endothelial function: targets for nutritional and pharmacological interventions. Journal of cardiovascular pharmacology, 2006, Volume: 47 Suppl 2 Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Arginine; Atherosclerosis; Biopterins; Cacao; Calcium Channel Blockers; Cyclooxygenase Inhibitors; Dyslipidemias; Endothelin-1; Endothelins; Endothelium, Vascular; Flavonoids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipoproteins, HDL; Nitric Oxide; Oxidative Stress; Reactive Oxygen Species	2006

Article

Year

Endothelial dysfunction in diabetes: multiple targets for treatment.

Pflugers Archiv : European journal of physiology, 2010, Volume: 459, Issue:6

Topics: Animals; Biological Factors; Biopterins; Blood Glucose; Calcium; Cell Communication; Connexins; Diabetes Mellitus; Diabetic Angiopathies; Dyslipidemias; Endothelium-Dependent Relaxing Factors; Endothelium, Vascular; Humans; Hypercalcemia; Hyperglycemia; Hypertension; Nitric Oxide Synthase Type III; Oxidative Stress; Transient Receptor Potential Channels

2010

Protection of endothelial function: targets for nutritional and pharmacological interventions.

Journal of cardiovascular pharmacology, 2006, Volume: 47 Suppl 2

Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Arginine; Atherosclerosis; Biopterins; Cacao; Calcium Channel Blockers; Cyclooxygenase Inhibitors; Dyslipidemias; Endothelin-1; Endothelins; Endothelium, Vascular; Flavonoids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipoproteins, HDL; Nitric Oxide; Oxidative Stress; Reactive Oxygen Species

2006

Other Studies

1 other study(ies) available for sapropterin and Dyslipidemia

Article	Year
Resveratrol improves vascular function in patients with hypertension and dyslipidemia by modulating NO metabolism. Hypertension (Dallas, Tex. : 1979), 2013, Volume: 62, Issue:2 Topics: Acetylcholine; Biopterins; Dyslipidemias; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; NF-E2-Related Factor 2; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Resveratrol; Stilbenes; Superoxide Dismutase; Vasodilation	2013

Article

Year

Resveratrol improves vascular function in patients with hypertension and dyslipidemia by modulating NO metabolism.

Hypertension (Dallas, Tex. : 1979), 2013, Volume: 62, Issue:2

Topics: Acetylcholine; Biopterins; Dyslipidemias; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; NF-E2-Related Factor 2; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Resveratrol; Stilbenes; Superoxide Dismutase; Vasodilation

2013